Assessment of renal function, Iatrogenic hyperkalemia and acute renal dysfunction in cardiology. Contrast-induced nephropathy;Valoración de afección renal, disfunción renal aguda e hiperpotasemia por fármacos usados en cardiología y nefrotoxicidad por contrastes

Revista Espanola de Cardiologia

Volumn 64, Issue 12, 2011, Pages 1182-1192

  Górriz Teruel, José Luis ^a   Beltrán Catalán, Sandra ^a  

^a HOSPITAL UNIVERSITARIO DR PESET   (Spain)

Author keywords

Albuminuria; Chronic kidney disease; Hyperkalemia; Renal dysfunction

Indexed keywords

CONTRAST MEDIUM;

ACUTE KIDNEY FAILURE; ARTICLE; CARDIOLOGY; CARDIOVASCULAR DISEASE; COCKCROFT GAULT FORMULA; CONTRAST INDUCED NEPHROPATHY; DIAGNOSTIC TEST; HUMAN; HYPERKALEMIA; KIDNEY FUNCTION; MATHEMATICAL PARAMETERS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK;

ACUTE KIDNEY INJURY; ALBUMINURIA; CARDIOLOGY; CONTRAST MEDIA; GADOLINIUM; HEART DISEASES; HUMANS; HYPERKALEMIA; IATROGENIC DISEASE; KIDNEY FAILURE, CHRONIC; PROGNOSIS; RENAL CIRCULATION; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS; RISK REDUCTION BEHAVIOR;

EID: 82155195819     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2011.08.012     Document Type: Article

References (66)

1. A.S. Go, G.M. Chertow, D. Fan, C.E. McCulloch, and C.Y. Hsu Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 2004 1296 1305
2. N.S. Anavekar, J.J. McMurray, E.J. Velazquez, S.D. Solomon, L. Kober, and J.L. Rouleau Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction N Engl J Med 351 2004 1285 1295 (Pubitemid 39258422)
3. K. Matsushita, M. Van der Velde, B.C. Astor, M. Woodward, A.S. Levey, and P.E. De Jong Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis Lancet 375 2010 2073 2081
4. United States Renal Data System (USRDS) 2004 annual report Am J Kidney Dis 45 Suppl 1 2005 S1 S56
5. A. Otero, A.L.M. De Francisco, P. Gayoso, F. García EPIRCE Study Group Prevalence of chronic renal disease in Spain: results of the EPIRCE study Nefrologia 30 2010 78 86
6. C.R. Sorensen, B. Brendorp, C. Rask-Madsen, L. Kober, E. Kjoller, and C. Torp-Pedersen The prognostic importance of creatinine clearance after acute myocardial infarction Eur Heart J 23 2002 948 952 (Pubitemid 35203873)
7. L. Facila, J. Núñez, V. Bodí, J. Sanchís, V. Bertomeu-González, and L. Consuegra Valor pronóstico de la creatinina sérica en el síndrome coronario agudo sin elevación del segmento ST Rev Esp Cardiol 59 2006 209 216 (Pubitemid 43674946)
8. D.J. Blackman, R. Pinto, J.R. Ross, P.H. Seidelin, D. Ing, and C. Jackevicius Impact of renal insufficiency on outcome after contemporary percutaneous coronary intervention Am Heart J 151 2006 146 152 (Pubitemid 41815345)
9. P.J. Best, R. Lennon, H.H. Ting, M.R. Bell, C.S. Rihal, and D.R. Holmes The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions J Am Coll Cardiol 39 2002 1113 1119 (Pubitemid 34267412)
10. W.A. Cooper, S.M. O'Brien, V.H. Thourani, R.A. Guyton, C.R. Bridges, and L.A. Szczech Impact of renal dysfunction on outcomes of coronary artery bypass surgery: results from the Society of Thoracic Surgeons National Adult Cardiac Database Circulation 113 2006 1063 1070
11. D.E. Forman, J. Butler, Y. Wang, W.T. Abraham, C.M. O'Connor, and S.S. Gottlieb Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure J Am Coll Cardiol 43 2004 61 67 (Pubitemid 38045917)
12. L. Grigorian, A. Varela Román, M. Pedreira Pérez, I. Gómez Otero, A. Virgós Lamela, and J.R. González-Juanatey La IR es un predictor independiente de la mortalidad en pacientes hospitalizados por insuficiencia cardíaca y se asocia con un peor perfil de riesgo cardiovascular Rev Esp Cardiol 59 2006 99 108
13. C. Ronco, P. McCullough, S.D. Anker, I. Anand, N. Aspromonte, S.M. Bagshaw Acute Dialysis Quality Initiative (ADQI) consensus group Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative Eur Heart J 31 2010 703 711
14. P.E. De Jong, and R.T. Gansevoort Fact or fiction of the epidemic of chronic kidney disease -let us not squabble about estimated GFR only, but also focus on albuminuria Nephrol Dial Transplant 23 2008 1092 1095 (Pubitemid 351767532)
15. M.M. Hermans, R. Henry, J.M. Dekker, J.P. Kooman, P.J. Kostense, and G. Nijpels Estimated glomerular filtration rate and urinary albumin excretion are independently associated with greater arterial stiffness: the Hoorn Study J Am Soc Nephrol 18 2007 1942 1952 (Pubitemid 46870332)
16. 2007 Guidelines for the management of arterial hypertension The task force for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology J Hypertens 25 2007 1105 1187
17. B.C. Astor, S.Y. Hallan, E.R. Miller, E. Yeung, and J. Coresh Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population Am J Epidemiol 167 2008 1226 1234 (Pubitemid 351670638)
18. National Kidney Fundation: K/DOQI Clinical practice guidelines for chronic kidney disease: Evaluation, classification and stratification. Am J Kidney Dis. 2002;39:S1-266.
19. D. De Zeew, H.H. Parving, and R.H. Henning Microalbuminuria as an early marker for cardiovascular disease J Am Soc Nephrol 17 2006 2100 2105 (Pubitemid 44141898)
20. H.C. Gerstein, J.F. Mann, Q. Yi, B. Zinman, S.F. Dinneen, B. Hoogwerf HOPE Study Investigators Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and non-diabetic individuals JAMA 286 2001 421 426 (Pubitemid 32681484)
21. H. Ibsen, M.H. Olsen, K. Watchell, K. Wachtell, K. Borch-Johnsen, and L.H. Lindholm Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: a LIFE study Hypertension 45 2005 2277 2284
22. S. Blecker, K. Matsushita, A. Köttgen, L.R. Loehr, A.G. Bertoni, and L.E. Boulware High-normal albuminuria and risk of heart failure in the community (ARIC study) Am J Kidney Dis 58 2011 47 55
23. X. Yang, R.C. Ma, W.Y. So, G.T. Ko, A.P. Kong, and C.W. Lam Impacts of chronic kidney disease and albuminuria on associations between coronary heart disease and its traditional risk factors in type 2 diabetic patients -the Hong Kong diabetes registry Cardiovasc Diabetol 6 2007 37
24. J. Redon Urinary albumin excretion: lowering the threshold of risk in hypertension Hypertension 46 2005 19 20 (Pubitemid 40946480)
25. R. Bigazzi, S. Bianchi, D. Baldari, and V.M. Campese Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension J Hypertens 16 1998 1325 1333 (Pubitemid 28408416)
26. American Diabetes Association Standards of Medical Care in Diabetes -2011 Diabetes Care 34 Suppl 1 2011 S11 S61
27. H.J. Mattix, C. Hsu Cy, S. Shaykevich, and G. Curhan Use of the albumin/creatinine ratio to detect microalbuminuria: Implications of sex and race J Am Soc Nephrol 13 2002 1034
28. D.W. Cockroft, and M.H. Gault Prediction of creatinine clearance from serum creatinine Nephron 16 1976 31 41
29. A.S. Levey, J.P. Bosch, J.B. Lewis, T. Greene, N. Rogers, and D. Roth A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group Ann Intern Med 130 1999 461 470 (Pubitemid 29135798)
30. A.S. Levey, L.A. Stevens, C.H. Schmid, Y.L. Zhang, A.F. Castro, and H.I. Feldman A new equation to estimate glomerular filtration rate Ann Intern Med 150 2009 604 612
31. N. Fontserré, J. Bonal, and R. Romero Métodos para la estimación de la función renal Med Clin (Barc) 129 2007 513 518
32. S. Gracia, R. Montañés, J. Bover, A. Cases, R. Deulofeu, and A.L. Martín de Francisco Recomendaciones sobre la utilización de ecuaciones para la estimación del filtrado glomerular en adultos Nefrologia 26 2006 658 665
33. R. Alcázar, M.I. Egocheaga, L. Orte, J.M. Lobos, E. González Parra, and F. Alvarez Guisasola Documento de consenso SEN-semFYC sobre la enfermedad renal crónica Nefrologia 28 2008 273 282
34. a ed. 2004 Elsevier Filadelfia 309 352
35. B.F. Palmer Renal dysfunction complicating the treatment of hypertension N Engl J Med 347 2002 1256 1261 (Pubitemid 35176246)
36. The Collaborative Study Group E.J. Lewis, L.G. Hunsicker, R.P. Bain, and R.D. Rohde The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy N Engl J Med 329 1993 1456 1462 (Pubitemid 23335891)
37. A.J. Apperloo, D. De Zeeuw, and P.E. De Jong A short-term antihypertensive treatment-induced fall in glomerular filtration rate predicts long-term stability of renal function Kidney Int 51 1997 793 797 (Pubitemid 27157964)
38. The SOLVD Investigators Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions N Engl J Med 327 1992 685
39. J.B. Young, M.E. Dunlap, M.A. Pfeffer, J.L. Probstfield, A. Cohen-Solal, and R. Dietz Mortality and morbidity reduction with candesartan in patients with chronic heart failure and left ventricular systolic dysfunction results of the CHARM low-left ventricular ejection fraction trials Circulation 110 2004 2618 2626 (Pubitemid 39456438)
40. ONTARGET Investigators, S. Yusuf, K.K. Teo, J. Pogue, L. Dyal, I. Copland, and H. Schumacher Telmisartan, ramipril, or both in patients at high risk for vascular events N Engl J Med 358 2008 1547 1559 (Pubitemid 351522739)
41. B. Jackson, B.P. McGrath, P.G. Matthews, C. Wong, and C.I. Johnston Differential renal function during angiotensin converting enzyme inhibition in renovascular hypertension Hypertension 8 1986 650
42. B.F. Palmer Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system N Engl J Med 351 2004 585 592
43. P. Ruggenenti, P. Cravedi, and G. Remuzzi The RAAS in the pathogenesis and treatment of diabetic nephropathy Nat Rev Nephrol 6 2010 319 330
44. B. Pitt, F. Zannad, W.J. Remme, R. Cody, A. Castaigne, and A. Perez The effect of spironolactone on morbidity and mortality in patients with severe heart failure (RALES study) N Engl J Med 341 1999 709 717 (Pubitemid 29407370)
45. B. Pitt, W. Remme, F. Zannad, J. Neaton, F. Martinez, and B. Roniker Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. EPHESUS Study N Engl J Med 348 2003 1309 1321 (Pubitemid 36384098)
46. F. Zannad, J.J. McMurray, H. Krum, D.J. Van Veldhuisen, K. Swedberg, and H. Shi Eplerenone in patients with systolic heart failure and mild symptoms N Engl J Med 364 2011 11 21
47. J. Ueda, A. Nygren, P. Hansell, and U. Erikson Influence of contrast media on single nephron glomerular filtration rate in rat kidney. A comparison between diatrizoate, iohexol, ioxaglate, and iotrolan Acta Radiol 33 1992 596 599
48. C.S. Rihal, S.C. Textor, D.E. Grill, P.B. Berger, H.H. Ting, and P.J. Best Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention Circulation 105 2002 2259 2264 (Pubitemid 34535335)
49. G. Marenzi, G. Lauri, E. Assanelli, J. Campodonico, M. De Metrio, and I. Marana Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction J Am Coll Cardiol 44 2004 1780 1785 (Pubitemid 39424075)
50. N.V. Guitterez, A. Diaz, G.C. Timmis, W.W. O'Neill, M.A. Stevens, and K.R. Sandberg Determinants of serum creatinine trajectory in acute contrast nephropathy J Interv Cardiol 15 2002 349 354 (Pubitemid 35257796)
51. R. Mehran, and E. Nikolsky Contrast-induced nephropathy: definition, epidemiology, and patients at risk Kidney Int 69 2006 S11 S15
52. C. Mueller Prevention of contrast-induced nephropathy with volume supplementation Kidney Int 69 2006 S16 S19
53. G.J. Merten, W.P. Burgess, L.V. Gray, J.H. Holleman, T.S. Roush, and G.J. Kowalchuk Prevention of contrast-induced nephropathy with sodium bicarbonate. A randomized controlled trial JAMA 291 2004 2328 2334 (Pubitemid 38656299)
54. M. Carraro, W. Mancini, M. Artero, F. Stacul, M. Grotto, and M. Cova Dose effect of nitrendipine on urinary enzymes and microproteins following non-ionic radiocontrast administration Nephrol Dial Transplant 11 1996 444 448 (Pubitemid 26092782)
55. S.K. Morcos Prevention of contrast media nephrotoxicity -the story so far Clin Radiol 59 2004 381 389 (Pubitemid 38559206)
56. J.G. Webb, G.E. Pate, K.H. Humphries, C.E. Buller, S. Shalatansky, and A. Al Shamari A randomized controlled trial of intravenous N acetylcysteine for the prevention of contrast induced nephropathy after cardiac catheterization: lack of effect Am Heart J 148 2004 422 429 (Pubitemid 39265114)
57. N. Pannu, B. Manns, H. Lee, and M. Tonelli Systematic review of the impact of N-acetylcysteine on contrast nephropathy Kidney Int 65 2004 1366 1374 (Pubitemid 38406975)
58. H. Trivedi, S. Daram, A. Szabo, A.L. Bartorelli, and G. Marenzi High dose N-acetylcysteine for the prevenetion of contrast-induced nephropathy Am J Med 122 2009 874 879
59. A. Alonso, J. Lau, B.L. Jaber, A. Weintraub, and M.J. Sarnak Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: a metaanalysis of randomized, controlled trials Am J Kidney Dis 43 2004 1 9 (Pubitemid 38049429)
60. G. Marenzi, E. Assanelli, I. Marana, G. Lauri, J. Campodonico, and M. Grazi N-acetylcysteine and contrast-induced nephropathy in primary angioplasty N Engl J Med 354 2006 2773 2782 (Pubitemid 43974195)
61. C. Briguori, and G. Marenzi Contrast-induced nephropathy: pharmacological prophylaxis Kidney Int 69 2006 S30 S38
62. C. Erley Concomitant drugs with exposure to contrast media Kidney Int 69 2006 S20 S24
63. H.S. Thomsen How to avoid CIN: guidelines from the European Society of Urogenital Radiology Nephrol Dial Transplant 20 Suppl 1 2005 i18 i22
64. S.K. Goergen Systematic review of current guidelines, and their evidence base, on risk of lactic acidosis after administration of contrast medium for patients receiving metformin Radiology 254 2010 261 269
65. P.A. McCullough, and K.R. Sandberg Epidemiology of contrast-induced nephropathy Rev Cardiovasc Med 4 Suppl 5 2003 S3 S9
66. J. Penfield, and R. Reilly What nephrologists need to know about Gadolinium Nat Clin Pract Nephrol 3 2007 654 688